Health and Fitness Health and Fitness
Thu, January 24, 2013
Wed, January 23, 2013
Tue, January 22, 2013
Mon, January 21, 2013
Fri, January 18, 2013
Thu, January 17, 2013
Wed, January 16, 2013
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013
Thu, January 10, 2013
Wed, January 9, 2013
Tue, January 8, 2013
[ Tue, Jan 08th 2013 ] - Market Wire
Cambridge Heart Provides Update
Mon, January 7, 2013
Sun, January 6, 2013
Fri, January 4, 2013
Thu, January 3, 2013
Wed, January 2, 2013
Mon, December 31, 2012
Fri, December 28, 2012
Thu, December 27, 2012
Wed, December 26, 2012
[ Wed, Dec 26th 2012 ] - Market Wire
30 p.m. ET
Mon, December 24, 2012
Fri, December 21, 2012
Thu, December 20, 2012
[ Thu, Dec 20th 2012 ] - Market Wire
A View from the Top

Morgan & Morgan investigates announced merger between Epocrates, Inc. and Athenahealth


//health-fitness.news-articles.net/content/2013/ .. rger-between-epocrates-inc-and-athenahealth.html
Published in Health and Fitness on Tuesday, January 8th 2013 at 7:16 GMT by Market Wire   Print publication without navigation


EPOC Shareholder Alert: Morgan & Morgan investigates announced merger between Epocrates,... -- NEW YORK, Jan. 8, 2013 /PRNewswire/ --

NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Morgan & Morgan is investigating potential claims against the board of directors of Epocrates, Inc. (NASDAQ: [ EPOC ]) related to the proposed acquisition of Epocrates by Athenahealth. The transaction values Epocrates at approximately $293 million or $11.75 per share.

If you are a current shareholder of Epocrates and are interested in learning more about our [ Epocrates merger investigation ] please contact George Pressly, Esq. at 1 (800) 631-6234 or email George at [ info@morgansecuritieslaw.com ].

Our investigation concerns whether Epocrates's board of directors has breached its fiduciary duties to act in the best interests of all of the Epocrates shareholders and to take all necessary steps to ensure that Epocrates shareholders receive the maximum value readily available for their shares of EPOC common stock.  This includes an examination of whether the board of directors properly shopped Epocrates before entering into this transaction, whether all material terms of the agreement have been properly disclosed to shareholders and whether $11.75 is a fair price. 

About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."  Investors may also follow us on Facebook at [ www.facebook.com/SecuritiesFraud ].

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
New York, NY 10036
1-800-631-6234
[ info@morgansecuritieslaw.com ]

 

SOURCE Morgan & Morgan



RELATED LINKS
[ http://www.securitieslawfirm.com ]

Publication Contributing Sources